Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other 1

Conditions

Obesity 11Mucositis 11Neoplasms 5Breast Neoplasms 5Polycystic Ovary Syndrome 4Dyspnea 4Sexual Dysfunction, Physiological 3Leukemia 3Hematologic Neoplasms 3Tongue Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Pain 2Overweight 2Obesity, Morbid 2Obesity, Abdominal 2Motor Activity 2Lymphoma 2Intestinal Obstruction 2Infertility 2Hodgkin Disease 2Head and Neck Neoplasms 2Fatigue 2Constipation 2Xerostomia 1Weight Loss 1Urinary Incontinence 1Triple Negative Breast Neoplasms 1Stress Disorders, Post-Traumatic 1Stomatitis 1

Interventions

Losartan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Radiation Fibrosis Syndrome × Other × Clear all
NCT00880386 2017-05-02

Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer

University of South Florida

Phase NA Withdrawn
OtherThoracic

Radiation Fibrosis Syndrome, Carcinoma, Non-Small-Cell Lung, Dyspnea, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡